STAT

The Readout Loud

Business EN ↓ 423 episodes

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Be sure to visit the podcast's website and support the creator: soundcloud.com

Author

STAT

Category

Business

Podcast website

soundcloud.com

Latest episode

Oct 23, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Episode 122: Gary Washburn on the NBA bubble, plus a DIY coronavirus vaccine, & behind VC numbers 30.07.2020

How much should a Covid-19 vaccine cost? What can basketball teach us about pandemic safety? And just how lucrative is venture capital?

Episode 121: Kate Bingham on vaccine data, Meg Tirrell on covering Covid-19, & a DNA detective story 23.07.2020

How soon will we get a Covid-19 vaccine? Why is biotech moving airline stocks? And what can we learn from 1860s science?

Episode 120: Moderna's vaccine data, saving the U.S. pandemic response & systemic racism in medicine 16.07.2020

What do we want from a coronavirus vaccine? Can the U.S.’s Covid-19 response be saved? And how can the field of medicine address structural racism?

Episode 119: Trump's FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine 09.07.2020

Who will stand up to the White House? How can hospitals protect workers from Covid-19? And what ever happened with Biogen?

Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life 02.07.2020

What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?

Episode 117: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus 25.06.2020

Is this a second wave or a rising tide? Who’s the real GlaxoSmithKline whistleblower? And what happens to cancer care in a pandemic?

Episode 116: Ezekiel Emanuel on vaccine politics & Tshaka Cunningham on diversifying genetic testing 18.06.2020

Can a vaccine be an October surprise? Are journal publishers running a racket? And why is genetics so white?

Episode 115: The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19 11.06.2020

Can a virtual conference feel real? Do scientists have a say in their benefactors' business? And what does it take to get remdesivir in the U.S.?

Episode 114: The killing of George Floyd, the drug industry's response, and what comes next 04.06.2020

The killing of George Floyd at the hands of a white Minneapolis police officer has brutally underlined the systemic racism that informs policing, housing, education, and health care in the U.S. This podcast covers the world of biotech, which, like every facet of our society, is affected by racism and inequality. So, first, we talk about how the drug industry has responded to Floyd’s killing and wh...

Episode 113: Life after a coronavirus vaccine, virtual ASCO, and remembering Larry Kramer 28.05.2020

What happens after we get a coronavirus vaccine? Can virtual medical meetings replace the real thing? And wasn’t Amazon supposed to disrupt health care?

Episode 112: Moderna's scant coronavirus data and the plight of the day trader 21.05.2020

When is a press release worth $5 billion? Can biotech stocks replace sports? And how will we know if a coronavirus vaccine actually works?

Episode 111: Covid-19 in the White House, a Parkinson’s experiment & public health lessons from porn 14.05.2020

What can the adult film industry teach us about fighting coronavirus? Does the FDA approve Zoom backgrounds? And is it ethical to fund a study of yourself?

Episode 110: Pandemic projections, Gilead's pricing dilemma & fighting Covid-19 in New York 07.05.2020

What if the curve just stays flat? How much should a Covid-19 drug cost? And what's it like on the ground in the epicenter of the novel coronavirus?

Episode 109: Scott Gottlieb on Covid-19 treatments, reopening America, and going on TV every day 30.04.2020

Just how well does Gilead Sciences' Covid-19 drug work? Is politics getting in the way of public health? And who gets the eventual coronavirus vaccine first?

Episode 108: A vaccine official is ousted, how to use ventilators, & the fate of the JPM conference 23.04.2020

Why was the infectious disease community in denial about the unfolding pandemic? When can we expect a vaccine? And are ventilators being overused?

Episode 107: Covid-19 disrupts D.C., how not to be boring on Zoom, and the trial of Elizabeth Holmes 16.04.2020

What's the proper distance to stand from Sen. Mitch McConnell? How many PowerPoint charts is too many? And when will Theranos get its day in court?

Episode 106: Privacy in a pandemic, biopharma's big opportunity, and Shkreli's plea for a break 09.04.2020

Can the drug industry win over Americans? Will the pandemic put an end to privacy? And could Martin Shkreli save the world?

Episode 105: Pandemic exit strategies, how the outbreak affects patients, and Ken Burns takes on DNA 02.04.2020

When will things go back to normal? What if a pandemic strikes when you're already sick? And what does Ken Burns know about genomics?

Episode 104: Fauci's star turn, the latest on coronavirus, and an under-the-radar Alzheimer's drug 26.03.2020

When can we stop distancing? Does the "deep state" meet over Zoom? And could the amyloid hypothesis come through at last?

Episode 103: Trump's coronavirus pivot, life inside the ICU & drug development in a pandemic 19.03.2020

Why did the U.S. change its tune on coronavirus? What's it like to be an ICU nurse right now? And when are we getting a vaccine?

Episode 102: Voices from the coronavirus pandemic, in Italy, New York, and the high seas 12.03.2020

How long will this pandemic persist? Are U.S. hospitals going to be overwhelmed? And what’s it like to be quarantined on a cruise ship?

Episode 101: Pharma’s response to coronavirus, Google's appetite for health data, & biotech in China 05.03.2020

Does “The Art of the Deal” cover vaccines? Is patient privacy a relic of the past? And how big can biotech get in China?

Episode 100: Wall Street's coronavirus freakout, clinical trial difficulties, and a look back 27.02.2020

Is the market overreacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce "Martin Shkreli"?

Episode 99: Genetic medicine w/ Ethan Weiss, drug industry infighting, & a microbiome review 20.02.2020

Can biopharma police itself? Who decides whether something's a disease or a difference? And will fecal matter ever become a drug?

Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy 13.02.2020

What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?

Listen to the The Readout Loud podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.